Cost-utility and cost-benefit analysis of pediatric PCV programs in Egypt

New vaccine introductions (NVIs) raise issues of value for money (VfM) for self-financing middle-income countries like Egypt. We evaluate a pediatric pneumococcal conjugate vaccine (PCV) NVI in Egypt from health payer and societal perspectives, using cost-utility and cost-benefit analysis (CUA, CBA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Sevilla, JP, Burnes, Daria, El Saie, Rehab Zakaria, Haridy, Hammam, Wasserman, Matt, Pugh, Sarah, Perdrizet, Johnna, Bloom, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Pneumococcal – Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746463/
https://www.ncbi.nlm.nih.gov/pubmed/36070504
http://dx.doi.org/10.1080/21645515.2022.2114252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746463/
https://www.ncbi.nlm.nih.gov/pubmed/36070504
http://dx.doi.org/10.1080/21645515.2022.2114252

Ejemplares similares